Canada markets closed

IGC Pharma, Inc. (IGC)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4900+0.0139 (+2.92%)
At close: 04:00PM EDT
0.4935 +0.00 (+0.71%)
After hours: 05:01PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-03-31
2022-03-31
2021-03-31
Total Revenue
1,343
911
397
898
Cost of Revenue
749
469
203
785
Gross Profit
594
442
194
113
Operating Expenses
Research Development
3,314
3,461
2,330
929
Selling General and Administrative
8,191
8,552
13,292
7,908
Total Operating Expenses
11,505
12,013
15,622
8,837
Operating Income or Loss
-10,911
-11,571
-15,428
-8,724
Total Other Income/Expenses Net
106
65
412
-87
Income Before Tax
-10,805
-11,506
-15,016
-8,811
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-10,805
-11,506
-15,016
-8,811
Net Income
-10,805
-11,506
-15,016
-8,811
Net Income available to common shareholders
-10,805
-11,506
-15,016
-8,811
Basic EPS
-0.20
-0.22
-0.30
-0.21
Diluted EPS
-0.20
-0.22
-0.30
-0.21
Basic Average Shares
53,383
52,576
49,992
41,963
Diluted Average Shares
53,383
52,576
49,992
41,963